Angiodynamics to report fiscal 2023 fourth quarter and full-year financial results on july 12, 2023

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that it will report financial results for the fourth quarter and fiscal year 2023 before the market open on wednesday, july 12, 2023. the company's management will host a conference call at 8:00 a.m. et the sam.
ANGO Ratings Summary
ANGO Quant Ranking